PsyBio Therapeutics Corp V.PSYB.H

Alternate Symbol(s): PSYBF

Healthcare Biotechnology

PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines, and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

TSXV:PSYB.H - Post by User

PsyBio Therapeutics Corp > Best Kept Secret on the TSX Venture

<< Previous

Bullboard Posts

Next >>

Comment by Bookworm28on Mar 18, 2021 5:12pm

83 Views

Post# 32829145

RE:RE:RE:RE:RE:RE:RE:RE:RE:Best Kept Secret on the TSX Venture

P.S. Thanks for the link. I thought the CEO's comments, "CEO Evan Levine said the biotechnology company has received a “tremendous amount of investment interest from top tier health care funds in its oversubscribed go public round”"

That statementiIs implies that there was some level of participation in the oversubscribed financing by at least one, if not more, top tier health care funds. Am I reading that right? Is there a way to verify that on paper? If it's true, I can't see us languishing in the low .40s.

CEO interview can be found at: https://tinyurl.com/49w6b7a9

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle